NEW NAPHTHALENE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

PROBLEM TO BE SOLVED: To provide a new naphthalene compound being a medicine for treating melatoninergic system disorder (melatonin is N-acetyl-5-methoxytryptamine), and having very valuable pharmacological characteristics related to a melatoninergic receptor, and to provide a pharmaceutical composi...

Full description

Saved in:
Bibliographic Details
Main Authors PERES BASILE, SPEDDING MICHAEL, MILLAN MARK, BERTHELOT PASCAL, SABAOUNI AHMED, DELAGRANGE PHILIPPE, YOUS SAID, CAIGNARD DANIEL HENRI
Format Patent
LanguageEnglish
Published 24.01.2008
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a new naphthalene compound being a medicine for treating melatoninergic system disorder (melatonin is N-acetyl-5-methoxytryptamine), and having very valuable pharmacological characteristics related to a melatoninergic receptor, and to provide a pharmaceutical composition containing the compound. SOLUTION: The pharmaceutical composition contains N-[(2S)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propanamide or N-[(2R)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propanamide, an enantiomer thereof and an addition salt thereof with a pharmaceutically acceptable base, in combination with one or more pharmaceutically acceptable vehicles. COPYRIGHT: (C)2008,JPO&INPIT
Bibliography:Application Number: JP20070171622